Continuing with Vivek Ramaswamy on the CDC making it harder for White Americans to get access to CHICOM-19 treatments, and not because any kind of evidence has come out that people of Caucasian descent are adversely impacted by the treatments over other groups (I'm not aware of any, to be clear).